PARTNERSHIPS
Enabling Unprecedented Multiomics Research
Our partnership with Olink is giving scientists a more comprehensive view of human biology, enabling clinicians to predict disease and outcomes, and deliver patients a whole new level of precision medicine.
We offer the following Olink platforms:
- Reveal
- Target 48/96
- Explore 1536/3072
- Explore HT
- Flex
- Focus
Olink Proteomics enables new discoveries across multiple disease areas with its innovative Proximity Extension Assay (PEA) using DNA coupled antibodies to identify and quantify protein biomarkers in clinical samples.
Services Enabled
Looking Deeper into Biological Systems
Psomagen is a 10x Certified Service Provider (CSP) for the following single-cell sequencing (SCS) applications:
- 3’ Gene Expression
- 5’ Gene Expression
- Immune Profiling
- Multiome ATAC + Gene Expression
- ATAC
This designation requires specialized training, evaluation, and yearly recertification, ensuring you receive the highest-standard SCS results.
10x Genomics is a life science technology company building products to help researchers interrogate, understand, and master biology.
Services Enabled
Production-Scale Multiomics Services
We're part of the first-ever group of Ultima Genomics Certified Service Providers. Selected because of our technical expertise, we were trained and tested to ensure Ultima users can sequence with confidence on their latest technologies.
Services Enabled
.png?width=364&height=138&name=PacBio_CSP%20(1).png)
Extended Reads with Long-Read Technology
Our labs are validated for HiFi sequencing on the PacBio Revio system. We stay up-to-date on PacBio's sample processing and data analysis workflows for high-quality results.
Scalable Single-Cell
Combinatorial barcoding uniquely tags mRNA within a cell. Cells are fixed and permeabilized, enabling long term storage and collection for longitudinal studies. Oligo-dT and random RNA capture possible.
Recent advancements in methodologies support a variety of projects:
- 3' gene expression
- Human TCR enrichment
- CRISPR screening
- Targeted gene capture
Services Enabled
Keeping an Eye on SARS-CoV-2
As an IDT AlignSM Preferred Sequencing Provider, IDT recognizes us as a cutting-edge and comprehensive sequencing provider. Together our companies share a commitment to collaborating and giving you access to cutting-edge technology and products.
IDT develops and manufactures nucleic acid products that support the life sciences industry.
Collaborations
Speeding Up Rare Disease Diagnosis
Rare disease patients are getting a diagnosis faster because we work with Fabric Genomics to create clinical reports from next-generation sequencing (NGS) patient data .
Together our teams are improving lives and helping patients get the right care on an expedited timeline.
Fabric Genomics offers a leading AI-based platform, NGS analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing.
Services Enabled
Supporting a Multiomics Approach
We’ve been working with Illumina technology for nearly two decades.
Our collaboration with their team of experts and ongoing commitment to staying up to date mean you receive the high-quality and high-throughput scalability of Illumina’s platforms without investing in the equipment or the expertise yourself.
Services Enabled
Affiliations
Keeping Up to Date on the COVID-19 Pandemic
SARS-CoV-2 Sequencing for Public Health Emergency Response, Epidemiology, and Surveillance (SPHERES) is an open genomics consortium established by the CDC’s Advanced Molecular Detection program in response to the COVID-19 pandemic.
Our participation keeps us up to date as new research and data changes our understanding of the disease, how it infects its hosts, and the best way to diagnose and treat patients.
Innovating Testing Through the Pandemic
The quality of COVID-19 testing is improved through the commitment and communication of members in the Bristol Myers Squibb COVID-19 Testing Industry Consortium.
We are proud to be one of 24 organizations participating in this important effort.
The consortium’s goal is to inform, improve, innovate, and accelerate various aspects of testing for COVID-19, ranging from research to clinical diagnostic applications.
